If someone in your house is suffering from diabetes, high blood pressure (BP), heart disease or weak bones, then this news has brought relief for you. The National Pharmaceutical Pricing Authority (NPPA) has fixed the maximum retail price of 39 essential medicines used on daily basis. This means that now these medicines will not be sold at a price higher than the prescribed limit. After this decision, many medicines can become cheaper by 20% to 40%.
This decision has been taken under the Drugs (Price Control) Order (DPCO), 2013. The aim of the government is to ensure that life-saving and essential medicines are available to every patient at affordable prices. The special thing is that this list includes only those medicines which are used the most in the country and which are used by lakhs of patients daily.
National Pharmaceutical Pricing Authority (NPPA) has capped the retail price of 39 medicines including that for hypertension, diabetes heart disease etc. pic.twitter.com/7vpm5U9cCC
— ANI (@ANI) July 11, 2026
Which patients will benefit?
The medicines included in the new list are mainly used to treat emergency conditions like high blood pressure, heart disease, diabetes, calcium deficiency, eye infections and rabies. Treatment of these diseases often lasts for a long time. In such a situation, even a small decrease in the price of medicine has a big impact on the patients’ pockets in a month and a year.
Now pharmaceutical companies and medical stores will not be able to sell these medicines more than the maximum price fixed by NPPA. Companies will also have to update the new MRP on medicine packets, so that patients can know the correct price.
Which major medicines became cheaper?
1. The most common medicine for heart patients
Clopidogrel + Aspirin + Atorvastatin
This medicine is given to reduce the risk of heart attack and stroke. It helps in keeping the blood thin and controlling cholesterol.
New maximum price: ₹6.37 per capsule
2. Combination medicine for high blood pressure
Amlodipine + Bisoprolol + Telmisartan
This medicine is given to patients with severe high blood pressure so that BP is controlled and there is no extra pressure on the heart. New maximum price: ₹14.74 per tablet
3. Calcium and Vitamin D3
Among the most commonly prescribed supplements for the elderly, women and patients with weak bones.
New price: ₹8.93 per tablet (including GST)
4. Life saving injection in heart attack
Tenecteplase (TNK-TPA)
A life-saving injection used to dissolve blood clots during a heart attack.
New maximum price: ₹60,238.27 per vial
5. Eye drops used after eye surgery
Nepafenac + Moxifloxacin
Used to prevent infection and inflammation after surgery such as cataract.
New price: ₹68.64 per ml
6. Necessary injection in case of dog or infected animal bite
Anti-Rabies Immunoglobulin
Important medicine to prevent rabies infection.
New Maximum Price: ₹119.48
How much impact will it have on patients’ pockets?
The government says that after fixing the prices of these medicines, the treatment of patients will be much cheaper than before. For example, heart and BP patients have to take many medicines every month. Earlier, branded leaves of these medicines were sold for Rs 250 to Rs 400. Now the government has fixed the maximum price per tablet. Due to this, in many cases the monthly medicine expenses of patients can be reduced by 20% to 40%.
What if a company charges higher prices?
NPPA has made it clear that no company can charge more than the fixed price. If any manufacturer or marketing company breaks the rules, action will be taken against it under DPCO-2013 and Essential Commodities Act, 1955. The company will have to deposit the entire additional recovered amount with the government along with interest.
What is NPPA?
The National Pharmaceutical Pricing Authority (NPPA) is an independent regulatory body of the Government of India, established in 1997. Its main function is to fix the prices of life-saving and essential medicines and to ensure that pharmaceutical companies do not charge arbitrary prices.
Why was this decision necessary?
The number of patients suffering from diabetes, high blood pressure and heart diseases is continuously increasing in India. According to health economists, 20% to 30% of the monthly budget of families with elderly and chronically ill patients is spent only on medicines. The World Health Organization (WHO) also believes that the out-of-pocket expenditure on health in India is much higher than the global average. In such a situation, this decision to control the prices of essential medicines can prove to be a big relief for millions of patients.
Leave a Reply